Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer. - Wikidata - wikimedia - TriplyDB

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

http://www.wikidata.org/entity/Q33391448

about

Immunodetection of human topoisomerase I-DNA covalent complexes VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers.Linobiflavonoid inhibits human lung adenocarcinoma A549 cells: effect on tubulin protein.Modulatory Effect of Betulinic Acid on the Genotoxicity Induced by Different Mutagens in V79 Cells.Asymmetric α-hydroxylation of a lactone with vinylogous pyridone by using a guanidine-urea bifunctional organocatalyst: catalytic enantioselective synthesis of a key intermediate for (20S)-camptothecin analogues.Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.Characterization of Camptothecin-induced Genomic Changes in the Camptothecin-resistant T-ALL-derived Cell Line CPT-K5.

P2860

Q27324108-27646D3B-0469-4001-B120-41C928C8274E Q28596809-64FB7553-422C-4211-ABBD-0B9D10D6B5FF Q33440037-2ECA18CA-0ABF-43BC-9455-DBADAFE35F36 Q39093037-F1621775-130A-4DC5-90B5-8E05F356EBC0 Q40903088-F15F4621-CE81-4704-ACA6-587250A379D3 Q43464125-BC236975-AE3A-45C1-82DA-628CFB0B7AFF Q45200343-B472F3E2-F468-4B32-8827-55BA32D2DECC Q52678451-DED2BC99-5E16-42AD-9526-07E92704DDE5

P2860

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

http://www.wikidata.org/entity/Q33391448

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@ast

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@en

type

label

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@ast

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@en

prefLabel

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@ast

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@en

P1433

Q33391448-47EFF5DA-AE45-4BD0-A651-E01181F4B850

P1476

Q33391448-BE063DB4-EA6C-480C-B76B-D0451306B535

P2093

Q33391448-22F22C9A-0770-43E2-BFBB-7060E2E1909A

Q33391448-47D80C08-0DE4-4143-A7C8-30F4C737B5C7

Q33391448-5220B989-98CA-4C11-9538-89899B3E7CC6

Q33391448-A250FC09-E1B2-4D6A-AD5F-953C850BBD93

Q33391448-DF5C4CF1-55DF-48D0-B1DB-F0917D329DBE

P275

Q33391448-3B3409DA-4BD8-4271-A287-FCE99FB71581

P2860

Q33391448-24612576-B463-457B-9C3D-895A1A084919

Q33391448-2EE7727C-5F05-4CA1-91A7-F1CB6BF94C49

Q33391448-3CCC97BD-6B95-451F-903A-C661EC4EFB9F

Q33391448-58F48CD7-91E6-40C2-99A0-502041B31F6C

Q33391448-7DEA5A37-7664-4105-BB65-B9F32A6DB9E8

Q33391448-88DC4309-FD1C-42E8-A41D-05C5B80402AE

Q33391448-8CFB4543-7E7F-4DC3-9BA9-A31E2944D0A0

Q33391448-AA3605EA-7D81-4AAD-8CB3-D3082FA05195

Q33391448-AD577086-60AE-43F3-90E3-E53CAC9EC679

Q33391448-B4E2CEEA-612B-4E9C-AC80-0301D18D320A

P2888

Q33391448-5CF9FC36-E281-4B05-94AD-175262FBA8AA

P304

Q33391448-F047E776-6ABF-492F-8BDE-F56FB9189EFE

P31

Q33391448-4C20DA24-172A-4E2B-9DB9-BAF4CE7361CC

Q33391448-834D7842-7E92-4D91-9E1F-3B3F6D162A47

P356

Q33391448-39272CB1-4D32-4A0C-AE38-3D7F25846868

P407

Q33391448-AFD2ECE7-559C-4514-A03B-E169209C6BD2

P478

Q33391448-E2E7240F-1593-4064-AA22-8FE67699AEF4

P5008

Q33391448-5B1D152E-1402-48AC-9423-3C0554525253

P577

Q33391448-04065684-DA16-4C57-9283-0AA1A7631F55

P5875

Q33391448-65CF7B24-4CC4-4EEA-8868-52BBCE1B3102

P6179

Q33391448-D0DEA0EA-AFE7-4659-A8C1-AC715B5EF973

P698

Q33391448-96865864-F533-402B-AF9F-06AC31A7D989

P921

Q33391448-291CB5D0-958A-4975-A11E-45B191251276

Q33391448-29E487F6-AC8A-4F5E-A7C9-66E5030F179E

Q33391448-87A498EE-1E73-43AA-B9B1-29CA259D3DF3

Q33391448-A381848C-ED5A-43E8-8E17-FEB1C58B5E9A

Q33391448-C5C29BA2-F576-4F9C-8C45-DAF0A63911B6

Q33391448-E97C19E1-0D25-4665-8E25-F0004C7AF882

P932

Q33391448-B18A5BF6-99F3-453B-9829-9050833AE1BA

P356

1471-2407-10-436

P1433

P1476

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.

@en

P2093

Caroline L Gooch

http://www.w3.org/2001/XMLSchema#string

Jean P Simons

http://www.w3.org/2001/XMLSchema#string

Jos Kleijnen

http://www.w3.org/2001/XMLSchema#string

Rob Riemsma

http://www.w3.org/2001/XMLSchema#string

Zahid Bashir

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.

Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.

Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer.

P2888

1471-2407-10-436

P304

436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-436

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2010-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45694390

http://www.w3.org/2001/XMLSchema#string

P6179

1004402054

http://www.w3.org/2001/XMLSchema#string

P698

20716361

http://www.w3.org/2001/XMLSchema#string

P921

lung small cell carcinoma

heterocyclic compound

mechanism of action

local neoplasm recurrence

P932

2931489

http://www.w3.org/2001/XMLSchema#string